These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36527826)

  • 1. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
    Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
    Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
    Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
    Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
    Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
    Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
    Lee D; Braly K; Nuding M; Braly I; Hopp C; Twible H; Pope C; Hayden HS; Hoffman L; Zheng H; Wahbeh G; Suskind DL
    J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1135-1142. PubMed ID: 38558411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
    Zhou S; Huang Z; Hou W; Lin Y; Yu J
    Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review.
    MacLellan A; Moore-Connors J; Grant S; Cahill L; Langille MGI; Van Limbergen J
    Nutrients; 2017 May; 9(5):. PubMed ID: 28468301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusive Enteral Nutrition Beneficially Modulates Gut Microbiome in a Preclinical Model of Crohn's-like Colitis.
    Geesala R; Recharla N; Zhang K; Johnson JC; Golovko G; Khanipov K; Brining DL; Shi XZ
    Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exclusive Enteral Nutrition Exerts Anti-Inflammatory Effects through Modulating Microbiota, Bile Acid Metabolism, and Immune Activities.
    Xiao F; Gao X; Hu H; Le J; Chen Y; Shu X; Liang Z; Xu Y; Wang Y; Zhang T
    Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition.
    Quince C; Ijaz UZ; Loman N; Eren AM; Saulnier D; Russell J; Haig SJ; Calus ST; Quick J; Barclay A; Bertz M; Blaut M; Hansen R; McGrogan P; Russell RK; Edwards CA; Gerasimidis K
    Am J Gastroenterol; 2015 Dec; 110(12):1718-29; quiz 1730. PubMed ID: 26526081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition.
    Gerasimidis K; Bertz M; Hanske L; Junick J; Biskou O; Aguilera M; Garrick V; Russell RK; Blaut M; McGrogan P; Edwards CA
    Inflamm Bowel Dis; 2014 May; 20(5):861-71. PubMed ID: 24651582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease.
    Diederen K; Li JV; Donachie GE; de Meij TG; de Waart DR; Hakvoort TBM; Kindermann A; Wagner J; Auyeung V; Te Velde AA; Heinsbroek SEM; Benninga MA; Kinross J; Walker AW; de Jonge WJ; Seppen J
    Sci Rep; 2020 Nov; 10(1):18879. PubMed ID: 33144591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn's disease.
    Jiang J; Chen L; Chen Y; Chen H
    BMC Gastroenterol; 2022 Apr; 22(1):212. PubMed ID: 35501724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
    Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease.
    Tang W; Huang Y; Shi P; Wang Y; Zhang Y; Xue A; Tang Z; Hu W; Sun H; Zhang P; Zheng C; Shi J; Wang S; Qiu X; Lu X; Miao S; Meng Y
    JPEN J Parenter Enteral Nutr; 2021 May; 45(4):826-838. PubMed ID: 32510616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn's disease.
    Nichols B; Briola A; Logan M; Havlik J; Mascellani A; Gkikas K; Milling S; Ijaz UZ; Quince C; Svolos V; Russell RK; Hansen R; Gerasimidis K
    Am J Clin Nutr; 2024 Apr; 119(4):885-895. PubMed ID: 38569785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease.
    Lv Y; Zhen C; Liu A; Hu Y; Yang G; Xu C; Lou Y; Cheng Q; Luo Y; Yu J; Fang Y; Zhao H; Peng K; Yu Y; Lou J; Chen J; Ni Y
    mSystems; 2024 Sep; 9(9):e0078324. PubMed ID: 39150251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteral Nutrition in the Management of Pediatric and Adult Crohn's Disease.
    Hansen T; Duerksen DR
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29701656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.
    Copova I; Hradsky O; Zarubova K; Gonsorcikova L; Potuznikova K; Lerchova T; Nevoral J; Bronsky J
    Eur J Pediatr; 2018 Nov; 177(11):1685-1693. PubMed ID: 30128744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
    Zubin G; Peter L
    Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn's Disease via Modulation of the Gut Microbiota.
    Gong D; Yu X; Wang L; Kong L; Gong X; Dong Q
    Biomed Res Int; 2017; 2017():8102589. PubMed ID: 29124070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.